DVA
59
-13
PYPL
31
6
AIZ
50
-2
VRSK
61
-2
SLG
31
3
LLY
60
-14
DE
63
5
FRT
51
-12
IP
53
5
GS
62
2
IPG
53
3
LB
53
3
AON
75
-3
BIIB
40
-2
PFG
52
-3
CCI
25
-3
EQT
60
3
CF
41
2
HSY
51
-2
ALL
50
-7
DVA
59
-13
PYPL
31
6
AIZ
50
-2
VRSK
61
-2
SLG
31
3
LLY
60
-14
DE
63
5
FRT
51
-12
IP
53
5
GS
62
2
IPG
53
3
LB
53
3
AON
75
-3
BIIB
40
-2
PFG
52
-3
CCI
25
-3
EQT
60
3
CF
41
2
HSY
51
-2
ALL
50
-7
Financhill
Back

Mynaric AG Vs. Sarepta Therapeutics Industry Stock Comparison

Sell
1

MYNA
Mynaric AG

Last Price:
$0.26
Seasonality Move:
8.04%
Sell
41

SRPT
Sarepta Therapeutics

Last Price:
$107.93
Seasonality Move:
1.75%
Sell
1
Mynaric AG (MYNA) is a Sell

Is Mynaric AG a Buy, Sell or Hold?

  • The current Mynaric AG [MYNA] share price is $0.26. The Score for MYNA is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
  • MYNA is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
41
Sarepta Therapeutics (SRPT) is a Sell

Is Sarepta Therapeutics a Buy, Sell or Hold?

  • The current Sarepta Therapeutics [SRPT] share price is $107.95. The Score for SRPT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • SRPT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MYNA Stock Price Chart

What is Mynaric AG's stock price today?

  • The Mynaric AG share price today is $0.26
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MYNA is experiencing slight selling pressure.

SRPT Stock Price Chart

What is Sarepta Therapeutics's stock price today?

  • The Sarepta Therapeutics share price today is $107.95
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and SRPT is experiencing selling pressure, which indicates risk of future bearish movement.

MYNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 40.68 Sell
Chaikin Money Flow: -1411070 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.35 - 0.57) Sell
Bollinger Bands (100): (0.52 - 1.42) Sell

SRPT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.94 Sell
Relative Strength Index (14 RSI): 33.84 Sell
Chaikin Money Flow: -502758 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (111.52 - 119.16) Sell
Bollinger Bands (100): (114.38 - 127.78) Sell

MYNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.36 Sell
20-day SMA: 0.44 Sell
50-day SMA: 0.56 Sell
200-day SMA: 2.32 Sell
8-day EMA: 0.38 Sell
20-day EMA: 0.44 Sell
50-day EMA: 0.63 Sell
200-day EMA: 2.01 Sell

SRPT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 111.57 Sell
20-day SMA: 114.25 Sell
50-day SMA: 119.8 Sell
200-day SMA: 128.55 Sell
8-day EMA: 110.88 Sell
20-day EMA: 113.91 Sell
50-day EMA: 117.81 Sell
200-day EMA: 123.39 Sell

Mynaric AG Earnings Growth & MYNA Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Sarepta Therapeutics Earnings Growth & SRPT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $2.70 per share, a decrease next quarter of $0.00 per share, an increase this year of $7.63 per share, and an increase next year of $4.84 per share.

Mynaric AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sarepta Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):